Detalles de la búsqueda
1.
Elements of successful NIH grant applications.
Proc Natl Acad Sci U S A
; 121(15): e2315735121, 2024 Apr 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-38557195
2.
IDH-mutant myeloid neoplasms are associated with seronegative rheumatoid arthritis and innate immune activation.
Blood
; 143(18): 1873-1877, 2024 May 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38457663
3.
Lineage-specific detection of residual disease predicts relapse in patients with chronic myeloid leukemia stopping therapy.
Blood
; 142(25): 2192-2197, 2023 12 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-37616555
4.
RaScALL: Rapid (Ra) screening (Sc) of RNA-seq data for prognostically significant genomic alterations in acute lymphoblastic leukaemia (ALL).
PLoS Genet
; 18(10): e1010300, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36251721
5.
Asciminib: a new therapeutic option in chronic-phase CML with treatment failure.
Blood
; 139(24): 3474-3479, 2022 06 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-35468180
6.
Special Issue "Advances in Molecular Pathogenesis and Targeted Therapies for Myeloid Neoplasms".
Int J Mol Sci
; 25(4)2024 Feb 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-38396733
7.
Case report: Rare case of donor cell-derived T-cell acute lymphoblastic leukaemia in a female patient after receiving an allo-transplant from her male sibling.
Br J Haematol
; 203(2): 282-287, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37519213
8.
Immune modulation in chronic myeloid leukaemia patients treated with nilotinib and interferon-alpha.
Br J Haematol
; 202(6): 1127-1136, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37482935
9.
Early BCR-ABL1 kinetics are predictive of subsequent achievement of treatment-free remission in chronic myeloid leukemia.
Blood
; 137(9): 1196-1207, 2021 03 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32871588
10.
Impact of additional genetic abnormalities at diagnosis of chronic myeloid leukemia for first-line imatinib-treated patients receiving proactive treatment intervention.
Haematologica
; 108(9): 2380-2395, 2023 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36951160
11.
B-cell acute lymphoblastic leukaemia: recent discoveries in molecular pathology, their prognostic significance, and a review of the current classification.
Br J Haematol
; 197(1): 13-27, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34747016
12.
Supporting discovery and development of medical countermeasures for chemical injury to eye and skin.
Exp Eye Res
; 221: 109156, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35716762
13.
A novel sulfur mustard (HD) vapor inhalation exposure model of pulmonary toxicity for the efficacy evaluation of candidate medical countermeasures.
Inhal Toxicol
; 33(6-8): 221-233, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34396872
14.
MLLT10 rearranged acute leukemia: Incidence, prognosis, and possible therapeutic strategies.
Genes Chromosomes Cancer
; 2020 Jul 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-32720323
15.
Clinical Effectiveness of Conjugate Pneumococcal Vaccination in Hematopoietic Stem Cell Transplantation Recipients.
Biol Blood Marrow Transplant
; 26(2): 421-427, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31627016
16.
The effect of co-occurring lesions on leukaemogenesis and drug response in T-ALL and ETP-ALL.
Br J Cancer
; 122(4): 455-464, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31792348
17.
Successful treatment-free remission in chronic myeloid leukaemia and its association with reduced immune suppressors and increased natural killer cells.
Br J Haematol
; 191(3): 433-441, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32352166
18.
Integrative genomic analysis reveals cancer-associated mutations at diagnosis of CML in patients with high-risk disease.
Blood
; 132(9): 948-961, 2018 08 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-29967129
19.
Supporting Fundamental Chemical Toxicology Research To Inform Medical Countermeasure Developments: The National Institutes of Health Chemical Countermeasures Research Program.
Chem Res Toxicol
; 33(4): 855-859, 2020 04 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-32196324
20.
The National Institutes of Health Chemical Countermeasures Research Program (NIH CCRP): A collaborative opportunity to develop effective and accessible chemical medical countermeasures for the American people.
Drug Dev Res
; 81(8): 907-910, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-32573018